Expiratory Time Constant in Mechanically Ventilated Patients

Sponsor
East Slovak Institute for Cardiovascular Diseases (Other)
Overall Status
Completed
CT.gov ID
NCT05827640
Collaborator
(none)
30
1
2.5
12

Study Details

Study Description

Brief Summary

Determining expiratory time constants in mechanically ventilated patients

Condition or Disease Intervention/Treatment Phase
  • Other: data recording using conventional ventilation strategies (PCV and VCV)

Detailed Description

Adult patients (n = 30) undergoing elective cardiac surgery with extracorporeal circulation (ECC) were included. Patients were excluded from the study if they had any known lung disease or had previous thoracic surgery. After the surgery, all patients were transferred to the intensive care unit (ICU) and connected to well-established Servo-U (Maquet, Getinge AB, Solna, Sweden) mechanical ventilator. First, the ventilation mode was set to mandatory volume-controlled ventilation (VCV) for 15 minutes. After that, mandatory pressure-controlled ventilation (PCV) for another 15 minutes was commenced. All patients were in supine position, sedated and paralyzed using continuous infusion of propofol and atracurium with no spontaneous breathing efforts. During VCV, an end-inspiratory pause (TPAUSE 10%) has been added to obtain inspiratory plateau pressure (P PLAT) under static conditions. Respiratory variables in VCV for all patients were as follows: PEEP 6 - 9 cmH 2 O depending on the local protocol, protective tidal volume (Vt) of 7 ml/kg/PBW, T PAUSE was set to 10%, I:E ratio of 1:2, rise time 5% and the respiratory rate was 14 breaths/min. After 15 minutes, VCV was changed to PCV with the same ventilator setting with inspiratory pressure set in the way to best match the Vt during the VCV. ARDSNet tables were used to determine PBW for all patients.

A novel device enabling data acquisition (Dr. Wave, Quadrus Medical Technologies, NY, White Plains, USA) has been connected to the Servo-U ventilator after admission to the ICU to record flow, pressure, and volume waveforms. All data in the study were derived from measurements and calculations from this device and included: Peak Inspiratory Pressure (PIP), PPLAT, PEEP, expiratory tidal volume (Vt) respiratory system compliance (C RS ), airway resistance (RTOT) and the peak expiratory flow rate (PEFR).

Based on obtained data of flow, volume and pressure during PCV and VCV, six different methods to determined expiratory time constant were examined

Study Design

Study Type:
Observational
Actual Enrollment :
30 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Determining Expiratory Time Constant in Mechanically Ventilated Patients
Actual Study Start Date :
Nov 15, 2022
Actual Primary Completion Date :
Jan 30, 2023
Actual Study Completion Date :
Jan 30, 2023

Outcome Measures

Primary Outcome Measures

  1. Expiratory time constant [3 months]

    Six different methods to assess expiratory time constants in mechanically ventilated patients

Secondary Outcome Measures

  1. Validity of expiratory time constant definition [3 months]

    To prove if three time constant correspond to actual first time constant multiplied by the factor of 3

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No

Inclusion Criteria: cardiac surgery with extracorporeal circulation

-

Exclusion Criteria:
  • known pulmonary disease

  • previous thoracic surgery

  • poor preoperative cardiac status

Contacts and Locations

Locations

Site City State Country Postal Code
1 East Slovak Institute for Cardiovascular Diseases Košice Slovakia 040 01

Sponsors and Collaborators

  • East Slovak Institute for Cardiovascular Diseases

Investigators

  • Study Director: Dušan Rybár, PhD, East Slovak Institute for Cardiovascular Diseases

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Filip Depta MD, MD, East Slovak Institute for Cardiovascular Diseases
ClinicalTrials.gov Identifier:
NCT05827640
Other Study ID Numbers:
  • www.vusch.sk
First Posted:
Apr 25, 2023
Last Update Posted:
Apr 25, 2023
Last Verified:
Apr 1, 2023
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Filip Depta MD, MD, East Slovak Institute for Cardiovascular Diseases

Study Results

No Results Posted as of Apr 25, 2023